A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting.
A Single Centre Randomized Control Trial of Donor Site Wound Dressing After Split Thickness Skin Grafting
1 other identifier
interventional
90
1 country
1
Brief Summary
The goal of this clinical trial\] is to compare different types of dressings used and there outcomes on STSG donor site wound. The main question\[s\] it aims to answer are:
- the effectiveness of different donor site dressings and their adverse outcomes
- the satisfaction of patients with the donor site dressing will be observed. Participants will randomly allocated different types of dressings for split thickness skin graft donor site wound which include alginate hydrocolloid hydrofiber silicon film guaze
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Aug 2022
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedFirst Submitted
Initial submission to the registry
September 4, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedSeptember 21, 2023
August 1, 2023
7 months
September 4, 2023
September 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
to asses the effective of dressings by measuring itching , pain and scarring
scaring by POSAS SCORE, pain and itcting by VISUAL ANALOGUE SCAORE.
six month
Secondary Outcomes (2)
patient satisfaction for scar
six months
any complications
six months
Study Arms (6)
alginate
EXPERIMENTALfilm
EXPERIMENTALguaze
EXPERIMENTALhydrocolloid
EXPERIMENTALhydrofiber
EXPERIMENTALsilicon
EXPERIMENTALInterventions
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
Eligibility Criteria
You may qualify if:
- Patients of aged 18 years and above of either gender underwent single donor-site wounds after split-skin grafting and surface area larger than 10 cm2 were included in the study
You may not qualify if:
- Patients on chemotherapy or corticosteroids were excluded from the study. Non-probability consecutive sampling was employed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Ruth KM Pfau civil hospital karachi
Karachi, Sindh, 74200, Pakistan
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2023
First Posted
September 21, 2023
Study Start
August 1, 2022
Primary Completion
February 28, 2023
Study Completion
February 28, 2023
Last Updated
September 21, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share